ENTA
ENANTA PHARMACEUTICALS INCCompany with tickers: ENTA
CIK
1177648
Shares Outstanding
29,019,344
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-11 | Vance Terry | Director | Award | 20,000 |
| 2026-03-11 | Russell Lesley | Director | Award | 20,000 |
| 2026-03-11 | Peterson Kristine | Director | Award | 20,000 |
| 2026-03-11 | Hata Yujiro S | Director | Award | 20,000 |
| 2026-03-11 | FOLETTA MARK G | Director | Award | 20,000 |
| 2026-03-11 | CARTER BRUCE L A | Director | Award | 20,000 |
| 2026-02-12 | Kowalsky Matthew Paul | Chief Legal Officer | Award | 1,318 |
| 2026-02-12 | Kowalsky Matthew Paul | Chief Legal Officer | Tax | 1,902 |
| 2026-02-12 | Luu Brendan | Chief Business Officer | Tax | 3,257 |
| 2026-02-12 | Luu Brendan | Chief Business Officer | Award | 1,575 |
| 2026-02-12 | Kieffer Tara Lynn | Chief Product Strategy Officer | Award | 1,575 |
| 2026-02-12 | Kieffer Tara Lynn | Chief Product Strategy Officer | Tax | 3,257 |
| 2026-02-12 | Rottinghaus Scott T. | Chief Medical Officer | Award | 1,650 |
| 2026-02-12 | Rottinghaus Scott T. | Chief Medical Officer | Tax | 3,413 |
| 2026-02-12 | Or Yat Sun | Chief Scientific Officer | Award | 1,650 |
| 2026-02-12 | Or Yat Sun | Chief Scientific Officer | Tax | 3,413 |
| 2026-02-12 | Luly Jay R. | Director, President and CEO | Award | 4,800 |
| 2026-02-12 | Luly Jay R. | Director, President and CEO | Tax | 6,155 |
| 2025-12-05 | Capps Kathleen S. | See Remarks | Sell | 323 |
| 2025-12-05 | Trout Harry R. III | See Remarks | Sell | 542 |
| 2025-12-05 | Rottinghaus Scott T. | Chief Medical Officer | Sell | 798 |
| 2025-12-05 | Luu Brendan | Chief Business Officer | Sell | 1,394 |
| 2025-12-05 | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | 2,106 |
| 2025-12-05 | Or Yat Sun | Chief Scientific Officer | Sell | 2,390 |
| 2025-12-05 | Luly Jay R. | Director, President and CEO | Sell | 4,743 |
| 2025-12-02 | Capps Kathleen S. | See Remarks | Sell | 207 |
| 2025-12-02 | Trout Harry R. III | See Remarks | Sell | 380 |
| 2025-12-01 | Capps Kathleen S. | See Remarks | Tax | 85 |
| 2025-12-01 | Trout Harry R. III | See Remarks | Tax | 105 |
| 2025-12-01 | Luu Brendan | Chief Business Officer | Tax | 498 |
| 2025-12-01 | Kieffer Tara Lynn | Chief Product Strategy Officer | Tax | 753 |
| 2025-12-01 | Or Yat Sun | Chief Scientific Officer | Tax | 753 |
| 2025-12-01 | Luly Jay R. | Director, President and CEO | Tax | 1,885 |
| 2025-11-25 | Trout Harry R. III | See Remarks | Award | 6,463 |
| 2025-11-25 | Trout Harry R. III | See Remarks | Award | 12,925 |
| 2025-11-25 | Luu Brendan | Chief Business Officer | Award | 90,000 |
| 2025-11-25 | Kieffer Tara Lynn | Chief Product Strategy Officer | Award | 100,000 |
| 2025-11-25 | Kowalsky Matthew Paul | Chief Legal Officer | Award | 90,000 |
| 2025-11-25 | Rottinghaus Scott T. | Chief Medical Officer | Award | 110,000 |
| 2025-11-25 | Or Yat Sun | Chief Scientific Officer | Award | 110,000 |
| 2025-11-25 | Luly Jay R. | Director, President and CEO | Award | 310,000 |
| 2025-11-25 | Capps Kathleen S. | See Remarks | Award | 6,325 |
| 2025-11-25 | Capps Kathleen S. | See Remarks | Award | 3,163 |
| 2025-08-26 | Trout Harry R. III | See Remarks | Other | 10,912 |
| 2025-08-26 | Trout Harry R. III | See Remarks | Other | 0 |
| 2025-08-26 | Capps Kathleen S. | See Remarks | Other | 5,829 |
| 2025-08-26 | Capps Kathleen S. | See Remarks | Other | 0 |
| 2025-08-08 | Rottinghaus Scott T. | Chief Medical Officer | Tax | 2,217 |
| 2025-03-13 | Vance Terry | Director | Award | 15,700 |
| 2025-03-13 | Russell Lesley | Director | Award | 15,700 |
| 2025-03-13 | Peterson Kristine | Director | Award | 15,700 |
| 2025-03-13 | Hata Yujiro S | Director | Award | 15,700 |
| 2025-03-13 | FOLETTA MARK G | Director | Award | 15,700 |
| 2025-03-13 | CARTER BRUCE L A | Director | Award | 15,700 |
| 2025-02-12 | Luu Brendan | Chief Business Officer | Tax | 3,326 |
| 2025-02-12 | Luu Brendan | Chief Business Officer | Award | 7,500 |
| 2025-02-12 | MELLETT PAUL J | Chief Fin. & Admin Officer | Tax | 3,326 |
| 2025-02-12 | MELLETT PAUL J | Chief Fin. & Admin Officer | Award | 7,500 |
| 2025-02-12 | Luly Jay R. | Director, President and CEO | Tax | 7,484 |
| 2025-02-12 | Luly Jay R. | Director, President and CEO | Award | 25,500 |
| 2025-02-12 | Luly Jay R. | Director, President and CEO | Buy | 45,000 |
| 2025-02-12 | Kieffer Tara Lynn | Chief Product Strategy Officer | Award | 7,500 |
| 2025-02-12 | Kieffer Tara Lynn | Chief Product Strategy Officer | Tax | 3,326 |
| 2025-02-12 | Rottinghaus Scott T. | Chief Medical Officer | Tax | 2,861 |
| 2025-02-12 | Rottinghaus Scott T. | Chief Medical Officer | Award | 9,750 |
| 2025-02-12 | Or Yat Sun | Chief Scientific Officer | Award | 9,750 |
| 2025-02-12 | Or Yat Sun | Chief Scientific Officer | Tax | 4,324 |
| 2024-12-06 | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | 2,283 |
| 2024-12-06 | Luu Brendan | Chief Business Officer | Sell | 2,283 |
| 2024-12-06 | Rottinghaus Scott T. | Chief Medical Officer | Sell | 866 |
| 2024-12-06 | Or Yat Sun | Chief Scientific Officer | Sell | 2,591 |
| 2024-12-06 | MELLETT PAUL J | Chief Fin. & Admin Officer | Sell | 2,591 |
| 2024-12-06 | Luly Jay R. | Director, President and CEO | Sell | 5,142 |
| 2024-12-01 | Luu Brendan | Chief Business Officer | Tax | 753 |
| 2024-12-01 | Kieffer Tara Lynn | Chief Product Strategy Officer | Tax | 753 |
| 2024-12-01 | Or Yat Sun | Chief Scientific Officer | Tax | 1,595 |
| 2024-12-01 | MELLETT PAUL J | Chief Fin. & Admin Officer | Tax | 1,595 |
| 2024-12-01 | Luly Jay R. | Director, President and CEO | Tax | 3,829 |
| 2024-11-27 | Kowalsky Matthew Paul | Chief Legal Officer | Award | 75,000 |
| 2024-11-27 | Luu Brendan | Chief Business Officer | Award | 75,000 |
| 2024-11-27 | Kieffer Tara Lynn | Chief Product Strategy Officer | Award | 81,000 |
| 2024-11-27 | Rottinghaus Scott T. | Chief Medical Officer | Award | 87,000 |
| 2024-11-27 | Or Yat Sun | Chief Scientific Officer | Award | 87,000 |
| 2024-11-27 | MELLETT PAUL J | Chief Fin. & Admin Officer | Award | 81,000 |
| 2024-11-27 | Luly Jay R. | Director, President and CEO | Award | 250,000 |
| 2024-08-08 | Rottinghaus Scott T. | Chief Medical Officer | Tax | 1,466 |
| 2024-07-15 | Rottinghaus Scott T. | Chief Medical Officer | Convert | 5,375 |
| 2024-07-15 | Rottinghaus Scott T. | Chief Medical Officer | Sell | 5,375 |
| 2024-07-15 | Rottinghaus Scott T. | Chief Medical Officer | Convert | 5,375 |
| 2024-07-12 | Rottinghaus Scott T. | Chief Medical Officer | Sell | 2,271 |
| 2024-07-11 | Rottinghaus Scott T. | Chief Medical Officer | Sell | 4,299 |
| 2024-06-17 | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | 7,266 |
| 2024-04-29 | Kowalsky Matthew Paul | Chief Legal Officer | Other | 0 |
| 2024-04-29 | Kowalsky Matthew Paul | Chief Legal Officer | Award | 150,000 |
| 2024-03-06 | Vance Terry | Director | Award | 15,700 |
| 2024-03-06 | Russell Lesley | Director | Award | 15,700 |
| 2024-03-06 | Peterson Kristine | Director | Award | 15,700 |
| 2024-03-06 | Hata Yujiro S | Director | Award | 15,700 |
| 2024-03-06 | FOLETTA MARK G | Director | Award | 15,700 |
| 2024-03-06 | CARTER BRUCE L A | Director | Award | 15,700 |